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ABSTRACT 
This study determined the prevalence of urinary tract infections in the Sudanese state of Khartoum and antimicro-
bial susceptibility pattern of isolated bacterial species. 200 adult patient urine specimens were collected and culti-
vated to identify the growing bacteria and their susceptibility to antibiotics. 35 % of specimens had significant 
bacterial growth. The most frequent isolates in this study were E. coli, E. faecalis and S. aureus. Most of the 
isolates were resistant to many antibiotics; Gram-negative and Gram-positive isolates were resistant to 67 % and 
44 % of the examined antibiotics, respectively. E. coli was the most frequent bacterium in the studied samples and 
it was highly resistant to first-line antibiotics. The most resistant bacteria isolated were Pseudomonas species and 
the lowest was for S. saprophyticus. The results highlighted the need for knowledge about antibiotic susceptibility 
profile of the bacteria causing UTI prior to antibiotic prescription in order to ensure optimal treatment. 
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INTRODUCTION 
Urinary tract infection (UTI) is the second 
most common infectious presenting in com-
munity practice. Worldwide, about 150 mil-
lion people are diagnosed with UTI each year 
(Gonzalez and Schaeffer, 1999). Almost 95 % 
of cases of UTIs are caused by bacteria 
(Bishop et al., 2007). Several studies show ge-
ographic variations in etiologic agents of 
UTIs and their resistance patterns to antibiot-
ics (Gupta, 2003; Akoachere et al., 2012). A 
study from 2006 carried out by Theodore 
(2006) in Nigeria found 141 out of 181 
(77.9 %) urine samples gave significant 
growth and the common isolates were E. coli, 
K. pneumoniae and S. aureus (Theodore, 
2006; Ebie et al., 2001; Burbige and Retik, 
1984). De Francesco et al. (2007) found that 
the most common causative agents of UTIs in 
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Italy were E. coli, E. faecalis, K. pneumoniae 
and P. mirabilis. In this context, Ahmed et al. 
(2000) reported that the most common urinary 
bacteria isolated in Sudan were E. coli, Kleb-
siella pneumoniae, and Proteus mirabilis 
(Ahmed et al., 2000). 
UTIs are often treated with broad-spec-
trum antibiotics that affect both Gram-posi-
tive and Gram-negative bacteria. However it 
might be more appropriate to use an antibiotic 
with a narrow spectrum activity that affects 
only Gram-positive or Gram-negative bacte-
ria because of concerns about infection with 
resistant organisms. Moreover, the extensive 
uses of antimicrobial agents have invariably 
resulted in the development of antibiotic re-
sistance, which has become a major problem 
worldwide (Kumar et al., 2006). 
The etiology of UTI and their antibiotic 
resistance have been changed over the past 
years, both in community and hospital-con-
tracted infection (Manges et al., 2006; Kahan 
et al., 2006). Gutpa et al. (1999) noted an 
alarming frequency of bacterial resistance. 
Most routinely used antibiotics had an overall 
sensitivity of less than 25 %; these included 
penicillin, ampicillin, oxacillin, streptomycin, 
tetracycline, chloramphenicol, carbenicillin 
and sulphonamides (Gupta et al., 1999). It 
was shown that resistance of E. coli and other 
uropathogens to ß-lactams, such as ampicil-
lin, and the first-generation cephalosporins 
has continued to increase in the past decade 
and now approaches 40 % in most studies 
(Gupta et al., 1999). 
Despite most Gram-negative uropatho-
gens are still susceptible to the combination of 
amoxicillin-clavulanate, the expense and gas-
trointestinal side effects of this drug make it a 
less desirable choice for empirical treatment 
of uncomplicated UTI (Gupta et al., 2001). 
However, it has been suggested that the fail-
ure rate with this drug is high when the bacte-
ria is resistant to ampicillin but susceptible to 
amoxicillin-clavulanate (Hooton and Stamm, 
1997). Whatever, fluoroquinolones are pre-
ferred, as initial agents for empiric therapy of 
UTI in area where resistance is likely to be of 
concern (Schaeffer, 2002; Biswas et al., 
2006), since they have high bacteriological 
and clinical cure rates, as well as low rates of 
resistance, among most common uropatho-
gens (Goldstein, 2000; Gupta et al., 2002; 
Tankhiwale et al., 2004). 
The previously reviewed studies uncov-
ered geographic variations in etiologic agents 
of UTIs and their resistance patterns to antibi-
otics (Gonzalez and Schaeffer, 1999; Bishop 
et al., 2007; Gupta, 2003; Akoachere et al., 
2012), however, in Sudan Ahmed et al. (2000) 
found that the most common urinary isolates 
were highly resistant when they were tested 
against ampicillin, amoxicillin, co-trimoxa-
zole, tetracycline, sulfonamide, trimethoprim, 
streptomycin, and carbenicillin (Gupta et al., 
2001). Unfortunately, there is not much infor-
mation on etiology and resistance pattern of 
community acquired UTIs in Sudan is availa-
ble, but helpfully, area-specific monitoring 
studies providing knowledge about the type of 
pathogens responsible for UTIs and their re-
sistance patterns may help the clinician to 
choose the right empirical treatment (Beyene 
and Tsegaye, 2011). Here we sought to deter-
mine prevalence of urinary tract infections in 
Khartoum state and antimicrobial susceptibil-
ity pattern of isolated bacterial species. 
 
MATERIAL AND METHODS 
Study design, area, and sample collection 
The study was a cross-sectional hospital 
based study. It was conducted in the academy 
teaching hospital, Khartoum teaching hospi-
tal, The Academy Charity Hospital and 
Yastabshiroon medical centre. It was carried 
out on samples from 200 subjects of unknown 
sex and age taken between August and No-
vember 2008, at the University of Medical 
Sciences and Technology, Microbiology La-
boratory. Two hundred mid-stream urine 
specimens were collected, as aseptically as 
possible, in a sterile wide-mouth container. It 
was not known whether the submitted urine 
came from patients with symptomatic upper 
or lower UTI or from patients with asympto-
matic bacteriuria or whether the urinary infec-
tion was complicated or uncomplicated. Since 
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urine itself is a good culture medium, all spec-
imens were processed by the laboratory 
within 2 hours of collection, or kept refriger-
ated at 4 ºC until delivery to the laboratory, 
and subsequently processed no more than 18 
hours after initial collection. 
Whenever possible, urine specimens for 
culture were collected in the morning. The pa-
tient was advised the night before to refrain 
from urinating before specimen collection. 
 
Cultivation of urine samples, identification 
of growing bacteria and susceptibility to  
antibiotics 
The urine samples were cultured on Mac-
Conkey and CLED agar plates and incubated 
aerobically at 37 °C overnight. Identification 
of growing bacteria was performed according 
to standard bacteriological methods. Sensitiv-
ity of bacteria to each antibiotic was carried 
out by measuring the diameter of inhibition 
zone of bacterial growth around the disc ac-
cording to standards for antimicrobial disk 
susceptibility tests of National Committee for 
Clinical Laboratory Standards (1997). 
Statistical analyses 
A chi-2 test was used for comparison be-
tween numbers of susceptible and resistant 
isolated bacterial species in addition to com-
pare antimicrobial resistance rate between 
Gram-negative and Gram-positive isolated 
bacteria. A p value of ≤ 0.05 was considered 
significant. 
 
RESULTS 
Prevalence and frequency of bacteria in 
urinary infection patient samples 
Out of the 200 urine specimens, 69 had 
significant bacterial growth giving so overall, 
bacterial prevalence was 34.5 %. The contam-
inated samples contained Escherichia coli, 
Enterococcus faecalis, Staphylococcus au-
reus, Proteus mirabilis, Klebsiella pneu-
moniae, Pseudomonas spp. and Staphylococ-
cus saprophyticus at 54, 19, 13, 4, 4, 3 and 
3 % respectively (Table 1). All infections 
were monocultures; no cases of multiple in-
fections were observed. 
 
 
 
 
Table 1: Number and frequency of isolated bacterial species from urine samples 
Isolated Bacteria Contaminated samples 
Number Percentage 
Gram-negative Bacteria Escherichia coli 37 54 
Klebsiella pneumoniae 3.0 4.0 
Proteus mirabilis 3.0 4.0 
Pseudomonas spp 2.0 3 
Gram-positive Bacteria Enterococcus faecalis 13 19 
Staphylococcus aureus 9.0 13 
Staphylococcus saprophyticus 2.0 3 
Total 69 100 
 
 
 
 
EXCLI Journal 2017;16:1073-1080 – ISSN 1611-2156 
Received: May 07, 2017, accepted: June 12, 2017, published: August 07, 2017 
 
 
1076 
Antimicrobial susceptibility of the isolated 
Gram-negative bacteria 
To determine numbers and rates of sus-
ceptible and resistant bacteria, the antimicro-
bial susceptibility test was performed for the 
isolates of the four Gram-negative bacteria 
that exposed to 14 common relevant antibiot-
ics: ampicillin, amikacin, cefotaxime, ciprof-
loxacin, ceftriaxone, amoxicillin, chloram-
phenicol, gentamicin, nalidixic acid, imi-
penem, norofloxacin, nitrofurantoin, co-tri-
moxazole and tetracycline. Numbers and rates 
of susceptible or resistant isolated Gram-neg-
ative bacteria were listed in Table 2. E. coli, 
K. pneumoniae, P. mirabilis and Pseudomo-
nas species showed high susceptible rates to 
gentamicin (Table 2). In contrast, these bacte-
rial species were found to have high resistant 
rates against ampicillin, amikacin, amoxicil-
lin, nitrofurantoin, co-trimoxazole and tetra-
cycline. Unfortunately, Pseudomonas species 
isolates were resistant to all used antibiotics 
in this study except gentamicin (Table 2). 
Antimicrobial susceptibility of the isolated 
Gram-positive bacteria 
To determine rates of susceptible and re-
sistant bacteria, the antimicrobial susceptibil-
ity test was performed for the isolates of the 
three gram-positive bacteria that exposed to 
14 common relevant antibiotics: ampicillin, 
vancomycin, cefotaxime, ciprofloxacin, 
amoxicillin, augmentin, chloramphenicol, 
erythromycin, nalidixic acid, imipenem, 
norofloxacin, nitrofurantoin, co-trimoxazole 
and penicillin. Numbers and rates of suscep-
tible or resistant isolated Gram-positive bac-
teria were listed in Table 3. S. aureus, S. sap-
rophyticus and E. faecalis showed high sus-
ceptible rates to vancomycin, ciprofloxacin, 
amoxicillin and norofloxacin. Fortunately, S. 
saprophyticus was highly sensitive to all used 
antibiotics in this study (Table 3). However, 
S. aureus and E. faecalis isolates were re-
sistant against cefotaxime, augmentin, eryth-
romycin, nalidixic acid, co-trimoxazole and 
penicillin (Table 3). 
 
 
Table 2: Antimicrobial susceptibility of Gram-negative isolates to tested antibiotics 
 Escherichia coli 
Number (%) 
K. pneumoniae 
Number (%) 
Protus mirabilis 
Number (%) 
Pseudomonas spp. 
Number (%) 
Antibiotic Sensitive Resistant Sensitive  Resistant Sensitive  Resistant Sensitive  Resistant 
Ampicillin 1 (2.7) 36 (97.3) 0 (0) 3 (100) 0 (0) 3 (100) 0 (0) 2 (100) 
Amikacin 17 (45.9) 20 (54.1) 3 (100) 0 (0) 1 (33.3) 2 (66.7) 1 (50) 1 (50) 
Cefotaxime 6 (16.2) 31 (83.8) 0 (0) 3 (100) 2 (66.7) 1 (33.3) 1 (50) 1 (50) 
Ciprofloxacin 18 (48.6) 19 (51.4) 2 (66.7) 1 (33.3) 3 (100) 0 (0) 0 (0) 2 (100) 
Ceftriaxone 22 (59.5) 15 (40.5) 1 (33.3) 2 (66.7) 2 (66.7) 1 (33.3) 1 (50) 1 (50) 
Amoxicillin 5 (13.5) 32 (86.5) 0 (0) 3 (100) 0 (0) 3 (100) 0 (0) 2 (100) 
Chloramphenicol 2 (5.4) 35 (94.6) 0 (0) 3 (100) 1 (33.3) 2 (66.7) 0 (0) 2 (100) 
Gentamicin 26 (70.6) 11 (29.4) 2 (66.7) 1 (33.3) 2 (66.7) 1 (33.3) 2 (100) 0 (0) 
Nalidixic acid 10 (27) 27 (73) 0 (0) 3 (100) 0 (0) 3 (100) 0 (0) 2 (100) 
Imipenem 20 (54.1) 17 (45.9) 1 (33.3) 2 (66.7) 0 (0) 3 (100) 1 (50) 1 (50) 
Norofloxacin 25 (67.6) 12 (32.4) 1 (33.3) 2 (66.7) 1 (33.3) 2 (66.7) 0 (0) 2 (100) 
Nitrofurantoin 13 (35.1) 24 (64.9) 0 (0) 3 (100) 1 (33.3) 2 (66.7) 0 (0) 2 (100) 
Co-trimoxazole 7 (18.9) 30 (81.9) 0 (0) 3 (100) 0 (0) 3 (100) 0 (0) 2 (100) 
Tetracycline 8 (21.6) 29 (78.4) 1 (33.3) 2 (66.7) 0 (0) 3 (100) 0 (0) 2 (100) 
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Table3: Antimicrobial susceptibility of Gram-positive isolates to tested antibiotics 
 S. aureus 
Number (%) 
S. saprophyticus 
Number (%) 
E. faecalis 
Number (%) 
Antibiotic Sensitive  Resistance Sensitive Resistance Sensitive  Resistence 
Ampicillin 3 (33.3) 6 (66.7) 2 (100) 0 13 (100) 0 
Vancomycin 5 (55.6) 4 (44.4) 2 (100) 0 8 (62) 5 (38) 
Cefotaxime 2 (22.2) 7 (77.8) 2 (100) 0 5 (38) 8 (62) 
Ciprofloxacin 5 (55.6) 4 (44.4) 2 (100) 0 13 (100) 0 
Amoxicillin 5 (55.6) 4 (44.4) 2 (100) 0 10 (77) 3 (23) 
Augmentin 4 (44.4) 5 (55.6) 2 (100) 0 7 (54) 6 (46) 
Chloramphenicol 5 (55.6) 4 (44.4) 2 (100) 0 5 (38) 8 (62) 
Erythromycin 3 (33.3) 6 (66.7) 2 (100) 0 8 (62) 5 (38) 
Nalidixic acid 5 (55.6) 4 (44.4) 2 (100) 0 3 (23) 10 (77) 
Imipenem 6 (66.7) 3 (33.3) 2 (100) 0 7 (54) 6 (46) 
Norofloxacin 6 (66.7) 3 (33.3) 2 (100) 0 10 (77) 3 (23) 
Nitrofurantoin 5 (55.6) 4 (44.4) 2 (100) 0 5 (38) 8 (62) 
Co-trimoxazole 4 (44.4) 5 (55.6) 2 (100) 0 5 (38) 8 (62) 
Penicillin 2 (22.2) 7 (77.8) 2 (100) 0 2 (15) 11 (85) 
 
 
Comparison between numbers of suscepti-
ble and resistant isolates to 14 utilized anti-
biotics 
Comparison between numbers of sensi-
tive and resistant Gram-negative isolates to 
the utilised 14 antibiotics disclosed that E. 
coli, K. pneumoniae, P. mirabilis and Pseudo-
monas species were sensitive to 35 %, 26 %, 
31 % and 21 % and resistant to 65 %, 74 %, 
69 % and 79 % of the antibiotics, respec-
tively. There was a very highly significant dif-
ference between the numbers of susceptible 
and resistant Gram-negative isolates (p ˂ 
0.0001). However, the total numbers of 
Gram-negative isolates were sensitive to 
33 % and resistant to 67 % of the 14 antibiot-
ics used in the study (Table 4). 
Comparison between numbers of sensi-
tive and resistant Gram-positive isolates to the 
relevant utilised 14 antibiotics disclosed that 
E. faecalis, S. aureus and S. saprophyticus 
were sensitive to 55.5 %, 48 % and 100 % and 
resistant to 44.5 %, 52 % and 0.0 % of the an-
tibiotics, respectively. There was a highly sig-
nificant difference between the numbers of 
susceptible and resistant Gram-positive iso-
lates (p ˂ 0.001). Whatever, the total number 
of Gram-positive isolates was sensitive to 
56 % and resistant to 44 % of the 14 antibiot-
ics used in the study (Table 4). 
 
DISCUSSION 
Here we determined the prevalence and 
frequency of antimicrobial susceptibility of 
bacterial species isolated from urine samples 
given by 200 adult Sudanese patients who 
presented with urinary disorders. 
We found that 69 (34.5 %) samples had 
significant bacterial growth and the common 
isolates were E. coli, E. faecalis and S. au-
reus. Prevalence of our findings was less than 
the prevalence of a Nigerian study from 2006 
carried out by Theodore who found 141 out of 
181(77.9 %) urine samples gave significant 
growth and the common isolates were E. coli, 
K. pneumoniae and S. aureus (Theodore, 
2006; Ebie et al., 2001; Burbige et al., 1984). 
In this context, Ahmed et al. (2000) from Su-
dan stated that the most common urinary bac-
teria isolated in his study were E. coli, 
Klebsiella pneumoniae, and Proteus mirabilis. 
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Table 4: Comparison between numbers of susceptible and resistant isolates to the 14 utilized antibiot-
ics 
Bacteria Number of isolated  
bacterial species 
Bacterial susceptibility to 14 antibiot-
ics 
P of χ2 
Sensitive (%) Resistant (%) Total 
Gram-
negative 
E. coli 37 180 (35) 338 (65) 518  
< 0.0001 K. pneumoniae 3 11(26) 31 (74) 42 
P. mirabilis 3 13(31) 29 (69) 42 
Pseudomonas spp 2 6 (21) 22 (79) 28 
Total of Gram-negative  45 210 (33) 420 (67) 630  
       
Gram-
positive 
E. faecalis 13 101 (55.5) 81 (44.5) 182  
< 0.001 S. aureus 9 60 (48) 66 (52) 126 
S. saprophyticus 2 28 (100) 0.0 (0.0) 28 
Total of Gram-positive 24 189 (56) 147 (44) 336  
      
Overall total 69 399 (41) 567 (59) 966 < 0.0001 
Our results are most similar to those of De 
Francesco et al. (2007) in Italy, who found 
that the most common causative agents of 
UTIs were E. coli, E. faecalis, K. pneumoniae 
and P. mirabilis. 
The common urinary bacteria isolated in 
our study were highly resistant to a number of 
the antimicrobial agents used, including am-
picillin, amoxicillin, chloramphenicol, co-tri-
moxazole, naladixic acid, tetracycline and ni-
trofurantoin, in agreement with the study per-
formed by Ahmed et al. (2000) in Sudan, the 
most common urinary isolates were highly re-
sistant when they were tested against ampicil-
lin, amoxicillin, co-trimoxazole, tetracycline, 
sulfonamide, trimethoprim, streptomycin, 
and carbenicillin. He found also that E. coli 
had a relatively low rate of resistance to nitro-
furantoin (17 %) (Ahmed et al., 2000), but un-
fortunately our results uncovered that E. coli 
resistance to nitrofurantoin increased to 65 %. 
In this context, Gupta et al. (1999) noted an 
alarming frequency of bacterial resistance. He 
found that most routinely used antibiotics had 
an overall sensitivity of less than 25 %; these 
included penicillin, ampicillin, oxacillin, 
streptomycin, tetracycline, chloramphenicol, 
carbenicillin and sulphonamides (Gupta et al., 
1999). Unfortunately, our results found that 
E. coli, K. pneumoniae, P. mirabilis and Pseu-
domonas species had an individual elevated 
resistance to the most of the utilized antibiot-
ics since these resistance rates were 65 %, 
74 %, 69 % and 79 %, respectively, giving an 
overall resistance rate of 67 % (Table 4). 
Nitrofurantoin and the fluoroquinolones 
are still effective in vitro against most E. coli 
isolates that cause uncomplicated commun-
ity-acquired UTI. Moreover, nitrofurantoin is 
less active against non E. coli Gram-negative 
rods and inactive against Proteus and Pseudo-
monas species (Gupta et al., 1999; Sham et 
al., 2001) and these findings were quite re-
lated to ours since 33 % of P. mirabilis was 
sensitive to nitrofurantoin and both K. pneu-
moniae and Pseudomonas species were re-
sistant (Table 2) to give an overall sensitivity 
rate of 11 % which was less than 25 % re-
ported by Gupta et al. (1999). 
In our study, the isolated Gram-positive 
bacteria were more sensitive to the antibiotics 
than Gram-negative isolates. It was found that 
E. faecalis, S. aureus and S. saprophyticus 
were sensitive to 55.5 %, 48 % and 100 % and 
resistant to 44.5 %, 52 % and 0.0 % of the rel-
evant antibiotics. In comparison, The Gram-
negative isolates E. coli, K. pneumoniae, P. 
mirabilis and Pseudomonas species were sen-
sitive to 35 %, 26 %, 31 % and 21 % and re-
sistant to 65 %, 74 %, 69 % and 79 % of the 
antibiotics (Table 4). However, the overall 
numbers of Gram-positive isolates were sus-
ceptible to 56 % and resistant to 44 % of the 
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relevant 14 antibiotics, while the overall num-
bers of Gram-negative isolates were suscepti-
ble to 41 % and resistant to 59 % of the anti-
biotics (p ˂ 0.0001). 
Finally, the Gram-positive isolates were 
most susceptible to vancomycin, ciprofloxa-
cin and augmentin while the Gram-negative 
isolates were most sensitive to ciprofloxacin, 
ceftriaxone and gentamicin (Tables 2 and 3). 
The resistance observed among most organ-
isms against the utilized antibiotics might be 
because these antibiotics have been in use for 
a long period and must have been abused and 
as a result the organisms must have developed 
mechanisms of circumventing their mode of 
action. 
Here we show that bacteria in Sudanese 
urinary infections frequently develop re-
sistance against 14 antimicrobial agents and 
thus we highlight a serious problem facing 
health authorities. However, we need more 
studies to uncover mechanisms behind this re-
sistance. A better understanding of these in 
situ processes is required in order to control 
the development, transmission, and evolution 
of antibiotic resistant genes (Lin et al., 2015). 
To develop new antibiotics, it is imperative to 
study the molecular basis of resistance devel-
opment so that we can prevent and overcome 
antibiotic resistance by targeting resistance 
mechanisms. This will also make the existing 
and novel antibiotics more effective and sus-
tainable (Lin et al., 2015). 
 
CONCLUSIONS 
E. coli was the most frequent bacterium in 
the studied urine samples and it was highly re-
sistant to the most utilized antibiotics as were 
the other bacteria identified in this study. Our 
data highlight the need for developing local 
guidelines where elevated resistance to anti-
biotics should influence prescribing deci-
sions. 
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